SCHEMBL7078472

SCHEMBL7078472

CCCCCCCCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1ccc(Cl)c(OCc2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
HPGD P15428 3/20 0.47
MAPT P10636 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
HDAC8 Q9BY41 2/20 0.44
CYP2D6 P10635 1/20 0.44
HTT P42858 1/20 0.44
CYP19A1 P11511 2/20 0.44
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
BRD4 O60885 2/20 0.42
PLK1 P53350 5/20 0.42
PLK3 Q9H4B4 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7164154 0.91 SMPD1 (0.45) HPGDALDH1A1KDM4ECYP1A2CYP2C9
SCHEMBL7077649 0.90 SMPD1 (0.54) SMN1; SMN2NPC1RAB9AHPGDKDM4E
SCHEMBL7164226 0.88 ALDH1A1 (0.42) SMN1; SMN2NPC1RAB9AHPGDALDH1A1
SCHEMBL7081540 0.87 AKR1C3 (0.58) SMN1; SMN2MAPTCYP1A2CYP19A1PLK1
SCHEMBL7083321 0.86 PLK1 (0.54) SMN1; SMN2NPC1RAB9AHDAC8HDAC1
SCHEMBL7077448 0.86 PLK1 (0.54) SMN1; SMN2NPC1RAB9AHDAC8HDAC1
SCHEMBL7080351 0.86 PLK1 (0.54) SMN1; SMN2NPC1RAB9AHDAC8HDAC1
SCHEMBL7080272 0.86 PLK1 (0.54) SMN1; SMN2NPC1RAB9AHDAC8HDAC1
SCHEMBL7080267 0.86 PLK1 (0.54) SMN1; SMN2NPC1RAB9AHDAC8HDAC1
SCHEMBL7081502 0.86 PLK1 (0.54) SMN1; SMN2NPC1RAB9AHDAC8HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN SMN1; SMN2 1718/4885NPC1 397/4885RAB9A 3579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.